サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514194

イメージング・エージェントの世界市場

Imaging Agents

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
イメージング・エージェントの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

イメージング・エージェントの世界市場は2030年までに米国で134億米ドルに達する見込み

2023年に98億米ドルと推定されるイメージング・エージェントの世界市場は、2023年から2030年にかけてCAGR 4.5%で成長し、2030年には134億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断用放射性医薬品は、CAGR 5.9%を記録し、分析期間終了時には72億米ドルに達すると予測されます。X線/CT分野の成長率は、分析期間中CAGR 3.3%と推定されます。

米国市場は27億米ドル、中国はCAGR 7.9％で成長予測

米国のイメージング・エージェント市場は2023年に27億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.3%と3.8%と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

世界のイメージング・エージェント市場- 主要動向と促進要因まとめ

診断用イメージング・エージェント（造影剤）は、疾患診断のためのイメージングプロセスを強化するために患者に投与される物質です。これらの薬剤は、X線、ガンマ線、音波、ラジオ波（MRI）、放射性粒子など、さまざまな方法で放射性医薬品がエネルギーを放出するのを助けます。画像のコントラストを向上させることで、ヘルスケア専門家が身体の構造をよりよく可視化・評価し、異常を検出することを可能にし、正確な診断のための重要な洞察を提供します。医用画像は、医師ががんから脳卒中まで様々な病気を診断するのに役立ち、何百万人もの命を救う重要なツールです。この分野を形成する最も影響力のある動向のひとつが人工知能（AI）です。

医療用画像診断の技術的進歩は可能性を広げ続け、より迅速で安全かつ効率的な画像診断につながっています。各社は先進技術と世界的に認められた安全プロトコルを活用し、包括的なイメージング・ソリューションを提供しています。画像診断の進歩の主な原動力には、AI、機械学習、ディープラーニングが含まれます。これらの技術はCTスキャン、MRI、超音波検査に統合され、ほぼ完璧な精度で反復作業を自動化し、従来の方法と比較してコストを削減します。ヘルスケアの専門家は、リスクを評価し、治療を調整し、最適で費用対効果の高い治療を保証するために、ますますAIベースのソリューションに依存しています。3D医療画像技術における仮想現実と拡張現実（VR/AR）は、2DのMRIやCTスキャンから3D画像を作成することで、複雑な構造の視覚化を強化します。VR/AR市場はまだ発展途上だが、ヘルスケアにおけるその変革の可能性は明らかになりつつあります。

核医学イメージングとウェアラブル技術もまた、医療用画像の進歩を促進しています。核医学イメージングでは、放射性トレーサーを使用して、がんやアルツハイマー病などの体内の状態に関する詳細な洞察を提供し、EXPLORER全身PET/CTスキャナーのような装置が効率を向上させています。ウェアラブルは、HD-DOT装置やウェアラブル超音波スキャナーにより、脳や臓器の継続的なモニタリングを可能にするなど、放射線医学に新たなアプリケーションを提供します。これらの技術革新は診断能力を拡大し、早期発見とより効果的な治療を提供することで患者の治療を改善しています。

調査対象企業の例（注目の23社）

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3336

Global Imaging Agents Market to Reach US$13.4 Billion by 2030

The global market for Imaging Agents estimated at US$9.8 Billion in the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the X-Ray / CT segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.9% CAGR

The Imaging Agents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Imaging Agents Market - Key Trends and Drivers Summarized

Diagnostic imaging agents, or contrast agents, are substances administered to patients to enhance the imaging process for disease diagnosis. These agents help radiopharmaceuticals emit energy using various methods, such as X-rays, gamma rays, sound waves, radio waves (MRI), and radioactive particles. By improving image contrast, they enable healthcare professionals to better visualize and assess body structures and detect abnormalities, providing critical insights for accurate diagnosis. Medical imaging is a critical tool that saves millions of lives by helping doctors diagnose diseases ranging from cancer to stroke. One of the most influential trends shaping this field is artificial intelligence (AI).

Technological progress in medical imaging continues to expand possibilities, leading to faster, safer, and more efficient imaging. Companies leverage advanced technology and globally accepted safety protocols to offer comprehensive imaging solutions. Key drivers in imaging advancements include AI, machine learning, and deep learning. These technologies are integrated into CT scans, MRIs, and ultrasounds to automate repetitive tasks with nearly perfect accuracy, cutting costs compared to traditional methods. Healthcare professionals increasingly rely on AI-based solutions to assess risk and tailor treatments, ensuring optimal, cost-effective therapy. Virtual and augmented reality (VR/AR) in 3D medical imaging technologies provide physicians with enhanced visualization of complex structures by creating 3D images from 2D MRI or CT scans. While the VR/AR market is still developing, its transformative potential in healthcare is becoming evident.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer's disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

Select Competitors (Total 23 Featured) -

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Imaging Agents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Enhanced Diagnostic Imaging
    • Nanotechnology Innovations Open New Frontiers in Imaging Agent Efficacy
    • Expansion of Personalized Medicine Strengthens the Business Case for Targeted Imaging Agents
    • Aging Global Population Increases Utilization of Imaging Services
    • Technological Advancements in Imaging Equipment Spur Demand for Compatible Agents
    • Safety Concerns and Side Effects Prompt Research into Alternative Imaging Agents
    • Rise of Theranostics Integrates Diagnostic and Therapeutic Capabilities in Single Agents
    • Growing Healthcare Expenditure Worldwide Expands Addressable Market for Imaging Agents
    • Emergence of Multi-modal Imaging Techniques Catalyzes Innovations in Agent Development
    • Shift Towards Minimally Invasive Procedures Enhances the Role of Imaging Agents
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for X-Ray / CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • JAPAN
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CHINA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • EUROPE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • FRANCE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • GERMANY
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • INDIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AFRICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030

IV. COMPETITION